Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.

Wakabayashi J, Higashi S, Morifuji M

RANDOMIZED CONTROLLED TRIAL 2026

DesignRANDOMIZED CONTROLLED TRIAL

TierTier 2, Product RCT (not peer-reviewed)

Year2026

JournalScientific reports

Nsee paper

Published2026 Jun 16

Added to NO1GEVITYSep 4, 2026

Cited by

1 encyclopedia entries reference this study.